These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2791345)

  • 1. Experience with intravenous immunoglobulin in myasthenia gravis.
    Arsura E
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S170-9. PubMed ID: 2791345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of autoimmune myasthenia gravis.
    Richman DP; Agius MA
    Neurology; 2003 Dec; 61(12):1652-61. PubMed ID: 14694025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis: prototype of the antireceptor autoimmune diseases.
    Schönbeck S; Chrestel S; Hohlfeld R
    Int Rev Neurobiol; 1990; 32():175-200. PubMed ID: 1706686
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic strategies for myasthenia gravis.
    Keys PA; Blume RP
    DICP; 1991 Oct; 25(10):1101-8. PubMed ID: 1803801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantiidiotypic antibodies in myasthenia gravis.
    Lefvert AK; Holm G; Pirskanen R
    Ann N Y Acad Sci; 1987; 505():133-54. PubMed ID: 3500664
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous immune globulin in myasthenia gravis.
    Gajdos P
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune Attack of the Neuromuscular Junction in Myasthenia Gravis: Nicotinic Acetylcholine Receptors and Other Targets.
    Paz ML; Barrantes FJ
    ACS Chem Neurosci; 2019 May; 10(5):2186-2194. PubMed ID: 30916550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
    Pachner AR
    Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis.
    Lagoumintzis G; Zisimopoulou P; Kordas G; Lazaridis K; Poulas K; Tzartos SJ
    Autoimmunity; 2010 Aug; 43(5-6):436-45. PubMed ID: 20187712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic immunoadsorption of acetylcholine receptor antibodies in myasthenia gravis.
    Sato T; Ishigaki Y; Komiya T; Tsuda H
    Ann N Y Acad Sci; 1988; 540():554-6. PubMed ID: 3061349
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible strategies for the treatment of myasthenia gravis and other autoimmune diseases.
    Nossal GJ
    Ann N Y Acad Sci; 1987; 505():610-8. PubMed ID: 3500669
    [No Abstract]   [Full Text] [Related]  

  • 15. Myasthenia gravis: emerging new therapy options.
    Sieb JP
    Curr Opin Pharmacol; 2005 Jun; 5(3):303-7. PubMed ID: 15907918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current trends in the management of myasthenia gravis: plasmapheresis and immunosuppressive therapy.
    Pollard JD; Basten A; Hassall JE; Kronenberg H; Cobcroft R; Dawkins R
    Aust N Z J Med; 1980 Apr; 10(2):212-7. PubMed ID: 6930213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance immunosuppression in myasthenia gravis.
    Gotterer L; Li Y
    J Neurol Sci; 2016 Oct; 369():294-302. PubMed ID: 27653912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of thymectomy on cellular immunity in myasthenia gravis.
    Tronconi BC; Morgutti M; Cornelio F; Clementi F
    Lancet; 1978 Jan; 1(8054):46-7. PubMed ID: 74527
    [No Abstract]   [Full Text] [Related]  

  • 19. Myasthenia gravis and autoimmunity.
    Whitaker JN
    Adv Intern Med; 1980; 26():489-510. PubMed ID: 6164271
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myasthenia gravis].
    Tanaka K
    Nihon Rinsho; 2004 May; 62 Suppl 5():580-5. PubMed ID: 15197988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.